133 related articles for article (PubMed ID: 35690501)
1. Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study.
Lightowler MS; Manangazira P; Nackers F; Van Herp M; Phiri I; Kuwenyi K; Panunzi I; Garone D; Marume F; Tarupiwa A; Ferreras E; Duri C; Luquero FJ
Vaccine; 2022 Jul; 40(31):4199-4210. PubMed ID: 35690501
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study.
Batool R; Tahir Yousafzai M; Qureshi S; Ali M; Sadaf T; Mehmood J; Ashorn P; Naz Qamar F
Vaccine; 2021 Sep; 39(40):5858-5865. PubMed ID: 34465474
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study.
Yousafzai MT; Karim S; Qureshi S; Kazi M; Memon H; Junejo A; Khawaja Z; Ur Rehman N; Ansari MS; Ali R; Ujjan IU; Lohana HM; Memon NM; Hussain M; Nigar R; Bar-Zeev N; Qamar FN
Lancet Glob Health; 2021 Aug; 9(8):e1154-e1162. PubMed ID: 34297962
[TBL] [Abstract][Full Text] [Related]
4. Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9 months to 15 years in Sindh, Pakistan.
Thobani RS; Yousafzai MT; Sultana S; Kazi AM; Jan M; Rafey A; Khan A; Irfan S; Ujjan IU; Brown N; Mårtensson A; Qamar FN
Vaccine; 2022 Aug; 40(36):5391-5398. PubMed ID: 35945044
[TBL] [Abstract][Full Text] [Related]
5. Population structure of Salmonella enterica Typhi in Harare, Zimbabwe (2012-19) before typhoid conjugate vaccine roll-out: a genomic epidemiology study.
Thilliez G; Mashe T; Chaibva BV; Robertson V; Bawn M; Tarupiwa A; Takawira FT; Kock MM; Midzi S; Mwamakamba LW; Matheu J; Juru A; Kingsley RA; Ehlers MM
Lancet Microbe; 2023 Dec; 4(12):e1005-e1014. PubMed ID: 37952554
[TBL] [Abstract][Full Text] [Related]
6. Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.
Hoffman SA; LeBoa C; Date K; Haldar P; Harvey P; Shimpi R; An Q; Zhang C; Jayaprasad N; Horng L; Fagerli K; Borhade P; Daruwalla S; Dharmapalan D; Gavhane J; Joshi S; Rai R; Rathod V; Shetty K; Warrier DS; Yadav S; Chakraborty D; Bahl S; Katkar A; Kunwar A; Yewale V; Andrews JR; Bhatnagar P; Dutta S; Luby SP
Clin Infect Dis; 2023 Jul; 77(1):138-144. PubMed ID: 36947143
[TBL] [Abstract][Full Text] [Related]
7. Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe.
Shaum A; Mujuru HA; Takamiya M; Ticklay I; Nathoo K; Sreenivasan N; Nyambayo P; Chitando P; Marembo J; Koline Chigodo C; Mukaratirwa A; Jacha V; Gidudu JF; Rupfutse M; Kumar Jain S; Manangazira P; Bennett SD
Vaccine; 2022 Jun; 40(26):3573-3580. PubMed ID: 35568590
[TBL] [Abstract][Full Text] [Related]
8. The effect of a comprehensive typhoid conjugate vaccine campaign on antimicrobial prescribing in children in Harare, Zimbabwe: a mixed methods study.
Olaru ID; Chingono RMS; Bottomley C; Kandiye FR; Mhino F; Nyamayaro CA; Manyau S; Vere M; Chitando P; Chonzi P; Darton TC; Dixon J; Kranzer K
Lancet Glob Health; 2023 Sep; 11(9):e1422-e1431. PubMed ID: 37591588
[TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine.
Yousafzai MT; Qamar FN; Shakoor S; Saleem K; Lohana H; Karim S; Hotwani A; Qureshi S; Masood N; Rauf M; Khanzada JA; Kazi M; Hasan R
Clin Infect Dis; 2019 Feb; 68(Suppl 1):S16-S21. PubMed ID: 30767003
[TBL] [Abstract][Full Text] [Related]
10. Typhoid Conjugate Vaccines: Advancing the Research and Public Health Agendas.
Birkhold M; Mwisongo A; Pollard AJ; Neuzil KM
J Infect Dis; 2021 Dec; 224(12 Suppl 2):S781-S787. PubMed ID: 34528085
[TBL] [Abstract][Full Text] [Related]
11. Parental acceptance of typhoid conjugate vaccine for children aged 6 months to 15 years in an outbreak setting of Lyari Town Karachi, Pakistan.
Batool R; Yousafzai MT; Qureshi S; Muhammad S; Qazi I; Sadaf T; Ashorn P; Qamar FN
Vaccine; 2023 Aug; 41(37):5376-5382. PubMed ID: 37463829
[TBL] [Abstract][Full Text] [Related]
12. Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal.
Shakya M; Colin-Jones R; Theiss-Nyland K; Voysey M; Pant D; Smith N; Liu X; Tonks S; Mazur O; Farooq YG; Clarke J; Hill J; Adhikari A; Dongol S; Karkey A; Bajracharya B; Kelly S; Gurung M; Baker S; Neuzil KM; Shrestha S; Basnyat B; Pollard AJ;
N Engl J Med; 2019 Dec; 381(23):2209-2218. PubMed ID: 31800986
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of TUBEX-TF and OnSite Typhoid IgG/IgM Combo rapid tests to detect Salmonella enterica serovar Typhi infection during a typhoid outbreak in Harare, Zimbabwe.
Tarupiwa A; Tapera S; Mtapuri-Zinyowera S; Gumbo P; Ruhanya V; Gudza-Mugabe M; Majuru NX; Chin'ombe N
BMC Res Notes; 2015 Feb; 8():50. PubMed ID: 25890321
[TBL] [Abstract][Full Text] [Related]
14. Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi.
Meiring JE; Laurens MB; Patel P; Patel P; Misiri T; Simiyu K; Mwakiseghile F; Tracy JK; Masesa C; Liang Y; Henrion M; Rotrosen E; Gmeiner M; Heyderman R; Kotloff K; Gordon MA; Neuzil KM
Clin Infect Dis; 2019 Mar; 68(Suppl 2):S50-S58. PubMed ID: 30845320
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children.
Patel PD; Patel P; Liang Y; Meiring JE; Misiri T; Mwakiseghile F; Tracy JK; Masesa C; Msuku H; Banda D; Mbewe M; Henrion M; Adetunji F; Simiyu K; Rotrosen E; Birkhold M; Nampota N; Nyirenda OM; Kotloff K; Gmeiner M; Dube Q; Kawalazira G; Laurens MB; Heyderman RS; Gordon MA; Neuzil KM;
N Engl J Med; 2021 Sep; 385(12):1104-1115. PubMed ID: 34525285
[TBL] [Abstract][Full Text] [Related]
16. Prospects of Future Typhoid and Paratyphoid Vaccines in Endemic Countries.
Shakya M; Neuzil KM; Pollard AJ
J Infect Dis; 2021 Dec; 224(12 Suppl 2):S770-S774. PubMed ID: 34374785
[TBL] [Abstract][Full Text] [Related]
17. Implementation of an outbreak response vaccination campaign with typhoid conjugate vaccine - Harare, Zimbabwe, 2019.
Poncin M; Marembo J; Chitando P; Sreenivasan N; Makwara I; Machekanyanga Z; Nyabyenda W; Mukeredzi I; Munyanyi M; Hidle A; Chingwena F; Chigwena C; Atuhebwe P; Matzger H; Chigerwe R; Shaum A; Date K; Garone D; Chonzi P; Barak J; Phiri I; Rupfutse M; Masunda K; Gasasira A; Manangazira P
Vaccine X; 2022 Dec; 12():100201. PubMed ID: 35983519
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study.
Phillips MT; Antillon M; Bilcke J; Bar-Zeev N; Limani F; Debellut F; Pecenka C; Neuzil KM; Gordon MA; Thindwa D; Paltiel AD; Yaesoubi R; Pitzer VE
BMC Infect Dis; 2023 Mar; 23(1):143. PubMed ID: 36890448
[TBL] [Abstract][Full Text] [Related]
19. Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan.
Qamar FN; Yousafzai MT; Khaliq A; Karim S; Memon H; Junejo A; Baig I; Rahman N; Bhurgry S; Afroz H; Sami U
Vaccine; 2020 Apr; 38(19):3518-3523. PubMed ID: 32201138
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial.
Shakya M; Voysey M; Theiss-Nyland K; Colin-Jones R; Pant D; Adhikari A; Tonks S; Mujadidi YF; O'Reilly P; Mazur O; Kelly S; Liu X; Maharjan A; Dahal A; Haque N; Pradhan A; Shrestha S; Joshi M; Smith N; Hill J; Clarke J; Stockdale L; Jones E; Lubinda T; Bajracharya B; Dongol S; Karkey A; Baker S; Dougan G; Pitzer VE; Neuzil KM; Shrestha S; Basnyat B; Pollard AJ;
Lancet Glob Health; 2021 Nov; 9(11):e1561-e1568. PubMed ID: 34678198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
